Literature DB >> 22750213

N-linked glycosylation of proline-rich membrane anchor (PRiMA) is not required for assembly and trafficking of globular tetrameric acetylcholinesterase.

Wallace K B Chan1, Vicky P Chen, Wilson K W Luk, Roy C Y Choi, Karl W K Tsim.   

Abstract

Acetylcholinesterase (AChE) is organized into globular tetramers (G(4)) by a structural protein called proline-rich membrane anchor (PRiMA), anchoring it into the cell membrane of neurons in the brain. The assembly of AChE tetramers with PRiMA requires the presence of a C-terminal "t-peptide" in the AChE catalytic subunit (AChE(T)). The glycosylation of AChE(T) is known to be required for its proper assembly and trafficking; however, the role of PRiMA glycosylation in the oligomer assembly has not been revealed. PRiMA is a glycoprotein containing two putative N-linked glycosylation sites. By using site-directed mutagenesis, the asparagine-43 was identified to be the N-linked glycosylation site of PRiMA. Abolishing glycosylation on mouse PRiMA appeared not to affect its assembly with AChE(T), the enzymatic properties of AChE, and the membrane trafficking of PRiMA-linked AChE tetramers. This result is contrary to the reports that glycosylation is essential for conformation and trafficking of membrane glycoproteins.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750213     DOI: 10.1016/j.neulet.2012.06.045

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Glycosylation of TRPM4 and TRPM5 channels: molecular determinants and functional aspects.

Authors:  Ninda Syam; Jean-Sébastien Rougier; Hugues Abriel
Journal:  Front Cell Neurosci       Date:  2014-02-24       Impact factor: 5.505

2.  Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.

Authors:  Maria-Letizia Campanari; Francisco Navarrete; Stephen D Ginsberg; Jorge Manzanares; Javier Sáez-Valero; María-Salud García-Ayllón
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.